Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
Omeros CorporationNASDAQ: OMER
Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026
Net change in cash turns negative
Q1 FY2026 net change in cash was -$7.75M, compared with $861K a year earlier. Trailing-twelve-month net change in cash was -$2.36M.
Context
- Net change in cash increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly net change in cash holds near -$7.75M or moves back toward the trailing-twelve-month quarterly average of -$588.75K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- 6.26M USD
- Year-over-year change
- +269.0%
- 4-year CAGR
- -48.7%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.26M | +269.0% |
| FY2024 | 2024-12-31 | (3.71M) | +5.1% |
| FY2023 | 2023-12-31 | (3.9M) | +95.7% |
| FY2022 | 2022-12-31 | (89.8M) | -199.4% |
| FY2021 | 2021-12-31 | 90.31M | — |
Net Change in Cash vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's LTM Mar 2026 net change in cash of $2.36M is the 9th largest of the 11 companies compared; the peer median is $7.67M.
- Its year-over-year change of -196.9% is the 7th highest of 10, against a peer median of -99.1%.
- Net change in cash amounts to 23.8% of revenue for OMER, versus a peer median of 64.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $149.83M | +233.4% | — | 64.5% | |
| LTM Jun 2026 | $98M | -206.5% | +7.5% | 83.8% | |
| LTM Mar 2026 | $79.05M | -221.2% | +105.0% | 50.3% | |
| LTM Dec 2025 | $72.37M | — | +192.0% | 99.5% | |
| LTM Jun 2026 | $71.63M | +197.7% | -7.7% | — | |
| LTM Mar 2026 | $35.1M | +1528.7% | -56.4% | — | |
| LTM Mar 2026 | $26.26M | -290.0% | -21.3% | 5252.0% | |
| LTM Jun 2026 | $15.21M | +1.2% | — | 27.9% | |
| LTM Mar 2026 | $2.36M | -196.9% | — | 23.8% | |
| LTM Mar 2026 | $1.57M | -164.9% | -61.9% | — | |
| LTM Jun 2026 | $126K | -99.1% | — | 0.1% | |
| Peer median (excluding OMER) | $7.67M | -99.1% | -7.7% | 64.5% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (191.55M) | (182.03M) | (117.81M) | (156.82M) | (3.35M) |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 11.65M | 10.49M | 8.19M |
| Change in Working Capital | (14.11M) | (118.97M) | 247.42M | 29.74M | 33.72M |
| Accounts Receivables | (34.31M) | (175.07M) | 245.72M | 40.01M | 30.45M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 14.64M | (10.67M) | 0 | 0 | 0 |
| Other Working Capital | 5.57M | 66.76M | 1.7M | (10.27M) | 3.27M |
| Other Non-Cash Items | 94.54M | 213.56M | (67.46M) | (33.17M) | (155.62M) |
| Operating Cash Flow | (109.72M) | (86.48M) | 74.73M | (148.8M) | (116.09M) |
| Capital Expenditures | (277K) | (113K) | (426K) | (165K) | (65K) |
| Acquisitions (Net) | 125.99M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (32.01M) | (429.05M) | (1.02B) | (987.39M) | (185.31M) |
| Sales of Investments | 100M | 301.59M | 1.05B | 1.07B | 109.9M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 240M |
| Investing Cash Flow | 193.71M | (127.56M) | 27.45M | 82.22M | 164.52M |
| Debt Repayment | (1.82M) | 123.83M | (101.58M) | (41.34M) | (89.16M) |
| Common Stock Issued | 8.38M | 415K | 0 | 0 | 46.99M |
| Common Stock Repurchased | 0 | 0 | (4.65M) | (11.85M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (241K) | 0 | 150K | 116.07M | 0 |
| Financing Cash Flow | 6.32M | 124.25M | (106.08M) | 62.88M | (42.17M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 90.31M | (89.8M) | (3.9M) | (3.71M) | 6.26M |
| Free Cash Flow | (110M) | (86.6M) | 74.3M | (148.97M) | (116.16M) |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.